Jae Ho Lo

906 total citations
29 papers, 547 citations indexed

About

Jae Ho Lo is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jae Ho Lo has authored 29 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Jae Ho Lo's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Mechanisms and Therapy (5 papers) and Ferroptosis and cancer prognosis (4 papers). Jae Ho Lo is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Mechanisms and Therapy (5 papers) and Ferroptosis and cancer prognosis (4 papers). Jae Ho Lo collaborates with scholars based in United States, Japan and Italy. Jae Ho Lo's co-authors include Heinz‐Josef Lenz, Francesca Battaglin, Shivani Soni, Wu Zhang, Hiroyuki Arai, Ryuma Tokunaga, Martin D. Berger, Alberto Puccini, Madiha Naseem and Hideo Baba and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Jae Ho Lo

23 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jae Ho Lo United States 10 254 193 159 104 100 29 547
Laura Mannarino Italy 10 188 0.7× 214 1.1× 119 0.7× 44 0.4× 120 1.2× 24 498
Yanping Zhong China 14 172 0.7× 161 0.8× 72 0.5× 42 0.4× 74 0.7× 37 476
Jole Ventriglia Italy 13 369 1.5× 111 0.6× 128 0.8× 24 0.2× 96 1.0× 36 547
Zhuangzhuang Liang China 10 221 0.9× 152 0.8× 108 0.7× 44 0.4× 53 0.5× 23 465
Baoen Shan China 15 173 0.7× 296 1.5× 67 0.4× 51 0.5× 66 0.7× 46 516
Kazuyuki Yamazumi Japan 8 336 1.3× 199 1.0× 130 0.8× 111 1.1× 55 0.6× 8 505
Erin Powell Canada 11 329 1.3× 148 0.8× 47 0.3× 50 0.5× 106 1.1× 26 543
Julien Lesage France 5 227 0.9× 255 1.3× 146 0.9× 25 0.2× 135 1.4× 6 576
Duygu Derin Türkiye 12 181 0.7× 178 0.9× 60 0.4× 28 0.3× 79 0.8× 24 424

Countries citing papers authored by Jae Ho Lo

Since Specialization
Citations

This map shows the geographic impact of Jae Ho Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae Ho Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae Ho Lo more than expected).

Fields of papers citing papers by Jae Ho Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jae Ho Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae Ho Lo. The network helps show where Jae Ho Lo may publish in the future.

Co-authorship network of co-authors of Jae Ho Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Jae Ho Lo. A scholar is included among the top collaborators of Jae Ho Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jae Ho Lo. Jae Ho Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soni, Shivani, Keehoon Lee, Kelvin Yen, et al.. (2025). Alterations in gut microbiome in age- and diet-induced colorectal cancer (CRC) progression in a preclinical model.. Journal of Clinical Oncology. 43(4_suppl). 223–223.
2.
Jayachandran, Priya, Andrew Elliott, Shivani Soni, et al.. (2025). Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer. Oncogene. 44(30). 2565–2573. 1 indexed citations
3.
Millstein, Joshua, Joanne Xiu, Shivani Soni, et al.. (2024). Clinical and molecular characterization of AXL in colorectal cancer: CALGB (Alliance)/SWOG 80405 and real-world data.. Journal of Clinical Oncology. 42(16_suppl). 3145–3145. 1 indexed citations
4.
Millstein, Joshua, Shivani Soni, Francesca Battaglin, et al.. (2024). Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.. Journal of Clinical Oncology. 42(3_suppl). 198–198.
5.
Yang, Yan, Joshua Millstein, Francesca Battaglin, et al.. (2024). Time to target TIM-3 in colorectal cancer: TIM-3 expression to predict survival outcomes in patients in CALGB (Alliance)/SWOG 80405.. Journal of Clinical Oncology. 42(16_suppl). 3583–3583.
6.
Lo, Jae Ho, Shivani Soni, Pooja Mittal, et al.. (2024). Abstract 7221: A compound targeting the circadian clock protein CRY2 enhances therapeutic efficacy of bevacizumab in a colorectal cancer (CRC) xenograft model. Cancer Research. 84(6_Supplement). 7221–7221. 1 indexed citations
7.
Wong, Alexandra C., Pooja Mittal, Jae Ho Lo, et al.. (2024). Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review. Cancers. 16(16). 2796–2796. 11 indexed citations
8.
9.
Jayachandran, Priya, Francesca Battaglin, Annika Lenz, et al.. (2023). Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions. Oncogene. 42(9). 627–637. 17 indexed citations
10.
Battaglin, Francesca, Joshua Millstein, Sebastian Stintzing, et al.. (2023). Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.. Journal of Clinical Oncology. 41(16_suppl). 3578–3578. 2 indexed citations
11.
Mittal, Pooja, Francesca Battaglin, Yasmine Baca, et al.. (2023). Characterization of MCL-1 in patients with colorectal cancer (CRC): Expression, molecular profiles, and outcomes.. Journal of Clinical Oncology. 41(16_suppl). 3085–3085. 1 indexed citations
12.
Lo, Jae Ho, Shivani Soni, Junxiang Wan, et al.. (2023). Abstract 4234: Effects of age-diet interactions on colorectal cancer (CRC) progression in mice. Cancer Research. 83(7_Supplement). 4234–4234.
13.
Battaglin, Francesca, Priya Jayachandran, Annika Lenz, et al.. (2022). Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment. Oncogene. 41(43). 4769–4778. 24 indexed citations
14.
Kawanishi, Natsuko, Joanne Xiu, Hiroyuki Arai, et al.. (2022). Hippo pathway signaling associated with immune cell trafficking in colorectal cancer.. Journal of Clinical Oncology. 40(4_suppl). 156–156. 1 indexed citations
15.
Tokunaga, Ryuma, Joanne Xiu, Richard M. Goldberg, et al.. (2020). The impact of ARID1A mutation on molecular characteristics in colorectal cancer. European Journal of Cancer. 140. 119–129. 52 indexed citations
16.
Tokunaga, Ryuma, Joanne Xiu, Curtis Johnston, et al.. (2019). Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer. Clinical Cancer Research. 25(10). 3096–3103. 62 indexed citations
17.
Arai, Hiroyuki, Francesca Battaglin, Jingyuan Wang, et al.. (2019). Molecular insight of regorafenib treatment for colorectal cancer. Cancer Treatment Reviews. 81. 101912–101912. 132 indexed citations
18.
Tokunaga, Ryuma, Madiha Naseem, Jae Ho Lo, et al.. (2018). B cell and B cell-related pathways for novel cancer treatments. Cancer Treatment Reviews. 73. 10–19. 169 indexed citations
19.
Carreño, Leandro J., Matthew J. Guberman‐Pfeffer, Pooja Arora, et al.. (2018). Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity. Cell chemical biology. 25(5). 571–584.e8. 32 indexed citations
20.
Tokunaga, Ryuma, Shu Cao, Madiha Naseem, et al.. (2018). Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy. Clinical Colorectal Cancer. 18(1). e8–e19. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Mannarino Breakdown of academic impact, for papers by Yanping Zhong Breakdown of academic impact, for papers by Jole Ventriglia Breakdown of academic impact, for papers by Zhuangzhuang Liang Breakdown of academic impact, for papers by Baoen Shan Breakdown of academic impact, for papers by Kazuyuki Yamazumi Breakdown of academic impact, for papers by Erin Powell Breakdown of academic impact, for papers by Julien Lesage Breakdown of academic impact, for papers by Duygu Derin
Rankless by CCL
2026